title: TWEAK binding to the Fn14 cysteine-rich domain depends on charged residues located in both the A1 and D2 modules.
abstract: TWEAK [TNF (tumour necrosis factor)-like weak inducer of apoptosis] is a member of the TNF superfamily of cytokines. TWEAK binds with high affinity to a single TNF receptor super-family member, Fn14 (fibroblast growth factor-inducible 14). This interaction can stimulate a variety of biological responses, depending on the cell type analysed. The murine Fn14 extracellular region is only 53 amino acids in length and primarily consists of a CRD (cysteine-rich domain) containing three disulphide bonds. In the present study, we investigated whether TWEAK binding to this CRD was dependent on selected evolutionarily conserved amino acid residues by using a site-specific mutagenesis approach and several different ligand-binding assays. Our results indicate that three residues within the predicted Fn14 CRD A1 module (Asp45, Lys48 and Met50) and one residue within the predicted D2 module (Asp62) are each critical for high-affinity TWEAK binding. Mutation of the three charged polar residues Asp45, Lys48 and Asp62 had the greatest deleterious effect, suggesting that electrostatic interactions between TWEAK and Fn14 residues may be particularly important for complex formation or stability. To determine whether the four critical residues were likely to be located on the Fn14 CRD surface, we made an Fn14 homology model based on a previously derived X-ray structure for the B-cell maturation antigen receptor, which also contains only one CRD. This model revealed that each of these critical residues were in areas of the receptor that are potentially capable of interacting with TWEAK. These results indicate that the TWEAK-Fn14 interaction is highly dependent on multiple Fn14 residues located in both CRD modules.
authors.affiliation: Department of Surgery, Center for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, 800 W. Baltimore St., Baltimore, MD 21201, USA.
authors.forename: Sharron A N
authors.initials: SA
authors.lastname: Brown
authors.forename: Heather N
authors.initials: HN
authors.lastname: Hanscom
authors.forename: Hong
authors.initials: H
authors.lastname: Vu
authors.forename: Shelesa A
authors.initials: SA
authors.lastname: Brew
authors.forename: Jeffrey A
authors.initials: JA
authors.lastname: Winkles
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D002460:Cell Line; D000074049:Cytokine TWEAK; D004220:Disulfides; D006801:Humans; D008024:Ligands; D008969:Molecular Sequence Data; D016297:Mutagenesis, Site-Directed; D009154:Mutation; D011485:Protein Binding; D017434:Protein Structure, Tertiary; D018124:Receptors, Tumor Necrosis Factor / Q000737:chemistry* / Q000378:metabolism; D000074050:TWEAK Receptor; D048069:Tumor Necrosis Factors / Q000737:chemistry* / Q000378:metabolism; D029867:Xenopus Proteins / Q000737:chemistry* / Q000378:metabolism; D014982:Xenopus laevis
chemical_list: D000074049:Cytokine TWEAK; D004220:Disulfides; D008024:Ligands; D018124:Receptors, Tumor Necrosis Factor; C581642:TNFRSF12A protein, Xenopus; C000613297:TNFRSF12A protein, human; D000074050:TWEAK Receptor; C000613299:Tnfrsf12a protein, mouse; C491645:Tnfsf12 protein, mouse; D048069:Tumor Necrosis Factors; D029867:Xenopus Proteins